New program aims to prevent second fractures in older women
NCT ID NCT01780012
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a program to help women over 50 who had a wrist or arm fracture get proper follow-up care for osteoporosis. The program included oral advice, a leaflet, and phone reminders to see their doctor and get a bone density test. 436 women took part, and the study compared those who got the program to those who received usual care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Osteoporosis prevention program (education, leaflet, phone reminders)
What this could lead to
If successful, this program could help more women get the bone care they need after a fracture, potentially preventing future breaks.
What could go wrong
This is a completed behavioral study, not a drug trial. The program may not change doctor or patient behavior as hoped, and results may not apply to all women.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS WITH CURRENT FRAGILITY FRACTURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pôle IMER, Hospices Civils de Lyon
Lyon, 69424, France